Abstract:Enrollment in Medicare Advantage (MA) has grown from 19% of eligible seniors in 2007 to 54% in 2024, 1 and the Centers for Medicare & Medicaid Services (CMS) projects continued growth in MA relative to traditional fee-for-service Medicare. Although most Medicare beneficiaries now choose MA plans, much of the extant evidence about health care cost, quality, and patient satisfaction for US seniors is based on data from the Medicare fee-for-service program, owing in part to the availability of patient data from CMS for traditional Medicare. The growth in MA enrollment and greater access to data from health plans participating in the program allow for more research examining potential differences among enrollees in MA vs traditional Medicare, and whether differences exist with regard to system and patient out-of-pocket costs, and both clinical quality and patient satisfaction with their care. 2 The article by Bejarano and colleagues 3 makes an important contribution to the growing literature on the patient experience and satisfaction with their care for seniors enrolled in the MA plan with a focus on 2 critical aspects of the options seniors have among MA plans. Bejarano and colleagues first distinguish between vertically integrated and nonintegrated plans and, second, between what they refer to as legacy and nonlegacy plans. Vertical integration is a common concept within industrial organization in which all the activities required to produce a good or service are conducted by a single firm, or a collection of firms contractually linked with one another. In health care, the fully vertically integrated health plan would include all of the services required for complete patient care. The authors define legacy integrated plans as those that were fully integrated before the recent growth in MA enrollment, demonstrating a long-term commitment to this care model and the ability to provide the full range of patient care services. Citing previous research, 4 Bejarano and colleagues note that nonlegacy plans may have formed more recently around MA business and lack the experience and organizational capacity of the more established legacy plans. By presenting their analysis of patient experience through the lens of integrated and legacy MA plans, Bejarano and colleagues 3 provide insights into the important heterogeneity that exists along the managed care spectrum. Their analysis reveals that a better patient experience was associated with integrated legacy plans, finding small and statistically significant results when examining the relative experience between all integrated and nonintegrated plans, with the greatest impact of legacy plans in patient experiences in customer service and getting appointments and care quickly. These results highlight the experience legacy plans have in patient engagement but may also point to the different care delivery models used by the 3 legacy plans identified in the article (Kaiser Permanente, Intermountain Health, and Geisinger). These plans have decades of experience providing integrated care using salaried clinicians practicing in owned and operated facilities. Nonlegacy, integrated MA plans are more likely to be offered by indemnity insurers using contractual relationships to achieve integration and, therefore, do not offer the same seamless experience that is offered by legacy plans. In addition to reporting clear differences in the patient experience between legacy and nonlegacy integrated MA plans, Bejarano and colleagues 3 provide important insights into the differences among the populations served by these plans, which will provide policy guidance for quality improvement efforts. The authors report that enrollees in legacy integrated plans are more likely than enrollees in nonlegacy plans to be White (77.4% vs 70.3%) and in excellent or very good health (42.1% vs 34.8%) but are less likely to dually eligible for Medicaid (6.8% vs 32.8%). These findings point to critical issues that CMS should consider when evaluating options to improve the MA program and are consistent with evidence from recent studies on MA plan enrollment showing that individuals from minoritized racial and ethnic groups, those in poorer health, and those more likely to have disability or to be experiencing financial distress are less likely to be enrolled in the higher performing MA plans. These findings are consistent with research by Park and colleagues, 5 who found no difference in CMS star quality ratings among integrated and nonintegrated MA plans but did find that that integrated plans were less likely to enroll individuals from socially marginalized groups. 5 This aligns with previous research by Park et al 6 that individuals from minoritized racial and ethnic groups have fewer options for enrolling in higher quality MA plans. Legacy and integrated MA plans -Abstract Truncated-

What Works in Managed Care—and What Doesn't

Parathyroid hormone and bone mass after kidney transplantation.

Managed competition in the United States: How well is it promoting equity and efficiency?

Specific ablation of the transcription factor CREB in sympathetic neurons surprisingly protects against developmentally regulated apoptosis

Understanding Patient Experience With Medicare Advantage

The History and Principles of Managed Competition

How Good is the Euclidean Distance Metric for the Clustering Problem

Optimizing health care delivery by integrating workplaces, homes, and communities: how occupational and environmental medicine can serve as a vital connecting link between accountable care organizations and the patient-centered medical home

In planta regulation of the Arabidopsis Ca(2+)/H(+) antiporter CAX1.

Community engagement in biobanking: Experiences from the eMERGE Network

The health care market: can hospitals survive?

So, you want to form a healthcare network - now what?

Carbamyl Phosphate Synthesis in the Earthworm Lumbricus terrestris

Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets

The California Competitive Model: How Has It Fared, And What's Next?

Nucleotide sequence of the structural gene encoding a 2-haloalkanoic acid dehalogenase of Pseudomonas putida strain AJ1 and purification of the encoded protein.

Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats.

Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans

Transformation of the Health Care Industry: Curb Your Enthusiasm?

Dialogue. Industry consolidation: what's at stake for consumers and purchasers?

Examining the scope of multibusiness health care firms: implications for strategy and financial performance